These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9881506)
1. Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity. Sandha GS; LeBlanc R; Van Zanten SJ; Sitland TD; Agocs L; Burford N; Best L; Mahoney D; Hoffman P; Leddin DJ Dig Dis Sci; 1998 Dec; 43(12):2727-32. PubMed ID: 9881506 [TBL] [Abstract][Full Text] [Related]
2. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. Scheen AJ Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
4. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464 [TBL] [Abstract][Full Text] [Related]
5. Healing of gastric body ulcer with gastroprotective versus antisecretory treatment. Jablonská M Dig Dis Sci; 1995 Sep; 40(9):2016-8. PubMed ID: 7555458 [TBL] [Abstract][Full Text] [Related]
7. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy. Phillips RH; Whitehead MW; Lacey S; Champion M; Thompson RP; Powell JJ Helicobacter; 2000 Sep; 5(3):176-82. PubMed ID: 10971684 [TBL] [Abstract][Full Text] [Related]
8. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Wagstaff AJ; Benfield P; Monk JP Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124 [TBL] [Abstract][Full Text] [Related]
9. Role of Bismuth in the Eradication of Helicobacter pylori. Alkim H; Koksal AR; Boga S; Sen I; Alkim C Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355 [TBL] [Abstract][Full Text] [Related]
10. Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics. Marcus EA; Sachs G; Scott DR Aliment Pharmacol Ther; 2015 Oct; 42(7):922-33. PubMed ID: 26238858 [TBL] [Abstract][Full Text] [Related]
11. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Hosking SW; Ling TK; Chung SC; Yung MY; Cheng AF; Sung JJ; Li AK Lancet; 1994 Feb; 343(8896):508-10. PubMed ID: 7906759 [TBL] [Abstract][Full Text] [Related]
12. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114 [TBL] [Abstract][Full Text] [Related]
13. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori? Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465 [TBL] [Abstract][Full Text] [Related]
14. Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro. Huesca M; Gold B; Sherman P; Lewin P; Lingwood C Zentralbl Bakteriol; 1993 Sep; 280(1-2):244-52. PubMed ID: 8280948 [TBL] [Abstract][Full Text] [Related]
15. Colloidal bismuth subcitrate in non-ulcer dyspepsia. Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406 [TBL] [Abstract][Full Text] [Related]
16. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation. Bland MV; Ismail S; Heinemann JA; Keenan JI Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188 [TBL] [Abstract][Full Text] [Related]
17. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro. Vogt K; Rodloff AC; Hahn H Infection; 1991; 19(3):138-9. PubMed ID: 1832417 [TBL] [Abstract][Full Text] [Related]
18. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori]. Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414 [No Abstract] [Full Text] [Related]
19. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340 [TBL] [Abstract][Full Text] [Related]
20. [Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression]. Folwaczny C Z Gastroenterol; 1995 Jul; 33(7):416-7. PubMed ID: 7571762 [No Abstract] [Full Text] [Related] [Next] [New Search]